|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Finished products | ||||||||||||||||||||
| Raw materials | ||||||||||||||||||||
| Products in process | ||||||||||||||||||||
| Operating supplies and other | ||||||||||||||||||||
| Accounts and notes receivable, gross | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Accounts and notes receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments and long-term receivables | ||||||||||||||||||||
| Property, plant & equipment, cost | ||||||||||||||||||||
| Allowances for depreciation, depletion & amortization | ||||||||||||||||||||
| Property, plant & equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Total short-term debt | ||||||||||||||||||||
| Trade payables and accruals | ||||||||||||||||||||
| Accrued salaries, wages and management incentives | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Pension and other postretirement benefits | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Noncurrent operating lease liabilities | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| Common stock, par value (in usd per share) | ||||||||||||||||||||
| Common stock, outstanding (in shares) | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock, $1 par value, Authorized 480.0 shares, Outstanding 129.4 , 130.6 and 132.0 shares, respectively | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
